All articles by Miranda Mclaren

Five common misconceptions about mobile visits in clinical trials

With decentralization now widely recognized as an established tool in the clinical trial toolbox, an increasing number of sponsors and…
Community research 101: Everything you need to know about mobile visits and community sites

DCTs seek to reduce the number of visits a participant is required to make to a clinical trial site –…
A quick guide to transferring a commercial drug product to a new fill-finish CDMO

Between 2012 and 2021, outsourcing propensity for FDA NDA injectables approvals averaged 40%, according to GlobalData’s Contract Injectable Packaging Trends…
What’s involved in designing effective lyophilization cycles?

Lyophilization, also referred to as freeze-drying, is a complex process that removes water from the drug product to preserve the…
Exploring Melbourne’s booming life sciences sector

Australia’s life sciences sector has seen rapid growth in the past decade. According to a 2022 report by AusBiotech, the…

Clinical trial access in the US: Where are today’s trials missing?

According to the latest data from CISCRP, the physical location/proximity of a research study center is one of the most…
The pros and cons of pooling supplies for clinical trials

Around ten years ago, everyone was talking about pooling supplies in clinical trials. Sharing drug products, especially in-house, seems like…
Outsourcing models for clinical trial support have evolved – has your RFP process?

Within the complex world of clinical trial outsourcing, drafting a request for proposal (RFP) to solicit comparative bids can be…
Cutting losses in drug manufacturing: A new era in fill-finish technology

Drug product loss is a necessary compromise to manufacture injectable medications. Traditional filling lines often incur losses exceeding one litre…
Decentralized Clinical Trials for older adults: Mobile research trends and recommendations

In the United States, the number of adults aged 65 and over is expected to grow sharply over the next…